Botanix Achieves Significant Results With Acne Drug

Botanix Pharma achieves statistically significant results with its acne drug BTX 1503, achieving the end-goal of reducing lesions. Today, Botanix Pharmaceuticals Limited (ASX:BOT) released an investor presentation that updated investors on the company's progress on its key clinical programs. A primary focus of the presentation was the additional analysis of the Phase 2 BTX 1503 … Continue reading Botanix Achieves Significant Results With Acne Drug